Stock Research

US stock-index futures advanced on Tuesday as chipmakers extended their rebound and easing tensions in the Middle East helped restore some appetite for risk. Futures tied to the S&P 500 rose about 0.39%, while Nasdaq 100 futures gained 0.67%. Futures linked to the Dow Jones Industrial Average advanced over 125 points, or 0.25%. The move… Continue reading Dow futures climb 125 points: 5 things to know before Wall Street opens

GlaxoSmithKline is making its largest oncology acquisition in years with a $10.6 billion deal for US-based cancer drug developer Nuvalent, betting that a trio of promising lung cancer therapies can help drive future growth and offset looming patent expirations in its HIV portfolio. The acquisition, announced on Tuesday, will give the British pharmaceutical giant access… Continue reading GSK’s $10.6B Nuvalent takeover fails to impress investors as shares fall: here’s why

SpaceX’s blockbuster IPO is attracting exactly the kind of demand many expected from Elon Musk’s most ambitious company. The offering is now reportedly oversubscribed ahead of its June 11 pricing, with institutional demand already exceeding the number of shares available. The strong interest highlights investor enthusiasm for a company that spans rockets, satellite internet, and… Continue reading SpaceX IPO is oversubscribed now: is it time to invest?

The upcoming initial public offering of SpaceX is triggering a wave of investor interest across Asia, with market participants seeking exposure to the Elon Musk-led company through exchange-traded funds and supply chain partners expected to benefit from the landmark listing. SpaceX is targeting a $75 billion fundraising and a valuation approaching $1.8 trillion, making it… Continue reading SpaceX IPO sparks global rally, Asian proxy plays lead gains

The UK’s benchmark FTSE 100 index moved lower on Tuesday, pressured by losses in healthcare giant GSK after the company announced plans to acquire shares of US-based drug developer Nuvalent in a deal valued at $10.6 billion. By 0810 GMT, the blue-chip FTSE 100 had slipped 0.3% to 10,341 points. In contrast, the mid-cap FTSE… Continue reading London’s FTSE 100 falls as GSK slides after Nuvalent deal

Shares of Indian banks rose more than 1% on Tuesday, making them the top-performing sectoral gainers after the Reserve Bank of India issued detailed guidelines for a concessional foreign exchange swap facility that lenders can use for overseas borrowings. The move forms part of a broader package of measures announced by the central bank to… Continue reading Indian banks lead market gains on RBI’s foreign deposit initiative

Samsung stock rebounded on Tuesday after Monday’s brutal selloff, giving investors a sharp reminder of how quickly the AI trade can swing from panic to bargain-hunting. The stock rose as much as about 5% in Seoul, a day after dropping 10.2% as South Korea’s benchmark KOSPI suffered one of its steepest falls in years. The… Continue reading Samsung rebounds 5% after crash: buy-the-dip moment or warning sign?

Asian stocks steadied on Tuesday, while oil eased from overnight highs, after Israel and Iran signalled a pause in attacks that gave investors a reason to buy back into battered risk assets. The rebound was clearest in markets that had suffered the sharpest falls a day earlier, with chip-heavy South Korea leading gains as traders… Continue reading Nikkei 225 soars as Asian markets rebound after circuit-breaker chaos

South Korea’s benchmark Kospi index has emerged as one of the standout performers this year – capturing headlines with record year-to-date gains of more than 70%. Yet, this meteoric rise has triggered a mass departure of foreign institutional capital, with investors offloading billions of dollars in domestic stocks. Net foreign outflows reached an estimated $62… Continue reading Foreign capital is fleeing South Korean stocks: here’s why you should buy instead